Financhill
Back

SpringWorks Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
48

SWTX
SpringWorks Therapeutics

Last Price:
36.98
Seasonality Move:
-1.67%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
45.38
Seasonality Move:
-13.89%
Sell
48
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $36.66. The Score for SWTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $45.11. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $36.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $45.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 42.2 Sell
Chaikin Money Flow: -294480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.12 - 39.8) Sell
Bollinger Bands (100): (38.52 - 47.72) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 60.77 Buy
Chaikin Money Flow: -97157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.74 - 44.22) Buy
Bollinger Bands (100): (40.25 - 47.53) Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.51 Sell
20-day SMA: 38.41 Sell
50-day SMA: 39.63 Sell
200-day SMA: 38.39 Sell
8-day EMA: 37.93 Sell
20-day EMA: 38.43 Sell
50-day EMA: 39.67 Sell
200-day EMA: 38.79 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.21 Buy
20-day SMA: 42.76 Buy
50-day SMA: 41.47 Buy
200-day SMA: 43.01 Buy
8-day EMA: 44.16 Buy
20-day EMA: 43.09 Buy
50-day EMA: 42.52 Buy
200-day EMA: 43.28 Buy

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $1.45 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):